TP53 and breast cancer: Moreover, these observations have been recapitulated in vitro, where mutant p53 regulation of cell cycle, apoptosis, Wnt, JAK-STAT, NOD-like receptor and glycolysis pathways were found to promote immunogenicity of cultured breast cancer cells.